S 2780 · 118th Congress · Commerce
Medication Affordability and Patent Integrity Act
Bill Progress
✓
Introduced2
Committee3
Senate Vote4
House5
EnactedLatest: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.(2023-09-13)
Plain Language Summary
[AI summary unavailable — showing source text]
[Congressional Bills 118th Congress] [From the U.S. Government Publishing Office] [S. 2780 Introduced in Senate (IS)] <DOC> 118th CONGRESS 1st Session S. 2780 To require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office. _______________________________________________________________________ IN THE SENATE OF THE UNITED STATES September 13, 2023 Ms. Hassan (for herself and Mr. Braun) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions _______________________________________________________________________ A BILL To require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Medication Affordability and Patent Integrity Act''. SEC. 2. DISCLOSUR…
Summarized by Claude AI · Non-partisan · For informational purposes only